Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes

OBJECTIVE: To examine the cost-effectiveness of a hepatitis B vaccination program for unvaccinated adults with diagnosed diabetes in the U.S. RESEARCH DESIGN AND METHODS: We used a cost-effectiveness simulation model to estimate the cost-effectiveness of vaccinating adults 20–59 years of age with di...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoerger, Thomas J., Schillie, Sarah, Wittenborn, John S., Bradley, Christina L., Zhou, Fangjun, Byrd, Kathy, Murphy, Trudy V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526214/
https://www.ncbi.nlm.nih.gov/pubmed/22933435
http://dx.doi.org/10.2337/dc12-0759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526214/
https://www.ncbi.nlm.nih.gov/pubmed/22933435
http://dx.doi.org/10.2337/dc12-0759

Ejemplares similares